Impact of Truncated Area on Point Estimate and Intra-Subject Variability in Bioequivalence of Dutasteride with Long Half-Life

• Published in: Drug research Vol. 68; no. 4; p. 238
• Main Authors: Prasaja, Budi, Harahap, Yahdiana, Lusthom, Windy, Yumi, Lia, Sofiana, Anna, Sandra, Monica, Safira, Falah, Chilmi, Uci
• Format: Journal Article
• Language: English
• Published: Germany 01.04.2018
• ISSN: 2194-9387
• DOI: 10.1055/s-0043-121695

To investigate the effect of using truncated area under the curve (AUC ) on bioequivalence of dutasteride with long half-life in point estimate and intra-subject variability. Fifteen subjects were enrolled in this single-dose, open-label, randomized two-way crossover design following an overnight fasting with five-week washout period. Plasma samples were collected to 72 h and 144 h following drug administration and dutasteride were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods. The pharmacokinetic parameters for bioequivalence assessment were AUC and AUC . The estimated point and the 90% confidence intervals were 91.07% (84.54-98.11%) for AUC and 91.43% (84.65-98.75%) for AUC , that is, within the ranges for acceptance of bioequivalence. The intra-subject variability's were 11.45% for AUC and 11.87% for AUC CONCLUSIONS: There was no statistically significant difference in point estimated and intra-subject variability between truncated AUC at 72 h and 144=h and the truncated AUC (AUC ) approach could be considered for bioequivalence assessment for dutasteride.